NewAmsterdam Pharma (NAMS) Asset Utilization Ratio (2024 - 2026)

NewAmsterdam Pharma has reported Asset Utilization Ratio for 3 years, with the latest figure at 0.03 in Q1 2026.

• Quarterly Asset Utilization Ratio fell 46.36% year-over-year to 0.03 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.03 (down 46.36% YoY) and the FY2025 annual result came in at 0.03, down 63.37% from the prior year.
• Asset Utilization Ratio climbed to 0.03 in Q1 2026 per NAMS's latest filing, from 0.03 in the prior quarter.
• Over five years, Asset Utilization Ratio peaked at 0.08 in Q2 2025 and troughed at 0.02 in Q2 2024.
• A 3-year average of 0.05 and a median of 0.04 in 2025 frame the typical range for Asset Utilization Ratio.
• The widest YoY moves for Asset Utilization Ratio: up 393.56% in 2025, down 58.61% in 2025.
• Over 3 years, Asset Utilization Ratio stood at 0.07 in 2024, then tumbled by 58.61% to 0.03 in 2025, then climbed by 3.87% to 0.03 in 2026.
• According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.03, 0.03, and 0.04 for Q1 2026, Q4 2025, and Q3 2025 respectively.